United States Department of Veterans Affairs
United States Department of Veterans Affairs

Office of Acquisition & Logistics

National Acquisition Center - Federal Supply Schedule Service - Pharmaceuticals - Public Law

Public Law 102-585, Veterans Health Care Act of 1992

The attached documents represent 1) "Dear Manufacturer" letters sent to contractors that have signed Master and Pharmaceutical Pricing Agreements with VA, pursuant to 38 U.S.C. 8126 (P.L. 102-585, Sec. 603); 2) Letters issued by the VA Office of General Counsel; and 3) Annual report filing instructions from the VA Pharmacy Benefit Management (PBM) Group.   The documents deal with various scenarios that have arisen over the years in the administration of the statute, and they contain VA's interpretation of the statute as applied to these situations.   The documents have been sent in hard copy form to all "covered drug" manufacturers during the annual Federal ceiling price recalculation periods.   However, they they have been issued only in years when there were significant questions of general application that required written resolution.   These letters will provide valuable guidance and information.   If you have any questions about the policies expressed in the letters, please contact Mr. Mel Noel, Contract Staff Attorney, VA Office of General Counsel, 708-786-5167 or mel.noel@va.gov.

Correspondence may be downloaded in Adobe Acrobat (.pdf) format below.  

Listing of Pharmaceutical Public Law Correspondence
Correspondence File Size
Dear Manufacturer of Covered Drugs 10/2007 Adobe Acrobat PDF Document hyperlink opens in a new browser window
62 kb
Dear Manufacturer of Covered Drugs 10/2006 Adobe Acrobat PDF Document hyperlink opens in a new browser window
62 kb
Dear Manufacturer FAMP Concerns 10/2004 Adobe Acrobat PDF Document hyperlink opens in a new browser window
77.1 kb
Dear Manufacturer of Covered Drugs letter 10/2004  Adobe Acrobat PDF Document hyperlink opens in a new browser window 33 kb
Dear Manufacturer of Covered Drugs 07/2004 Adobe Acrobat PDF Document hyperlink opens in a new browser window
32.1 kb
Office of General Counsel Letter 03/2004 Adobe Acrobat PDF Document hyperlink opens in a new browser window
regarding calculation of FCPs for Flu Vaccines
160 kb
Public Law Correspondence Index Adobe Acrobat PDF Document hyperlink opens in a new browser window
96 kb
Annual Guidance 10/2002 Adobe Acrobat PDF Document hyperlink opens in a new browser window
49 kb
Dear Manufacturer Letter 10/2001 Adobe Acrobat PDF Document hyperlink opens in a new browser window
regarding who is a manufacturer under a licensing agreement, determination regarding certain purchases by INS, exclusion of sales to § 602 entities at less than the statutory price through their PPV's, and calculation of new covered drug pricing
171 kb
Annual Guidance 10/2001 Adobe Acrobat PDF Document hyperlink opens in a new browser window
198 kb
Annual Guidance 10/2000 Adobe Acrobat PDF Document hyperlink opens in a new browser window
205 kb
Annual Guidance 10/1999 Adobe Acrobat PDF Document hyperlink opens in a new browser window
481 kb
Dear Manufacturer Cover Letter 10/1999 Adobe Acrobat PDF Document hyperlink opens in a new browser window
regarding all previous correspondence
83 kb
Annual Guidance 10/1998 Adobe Acrobat PDF Document hyperlink opens in a new browser window
533 kb
Office of General Counsel Letter 05/1998 Adobe Acrobat PDF Document hyperlink opens in a new browser window
regarding calculation of FCPs for Flu Vaccines
99 kb
Response to Pharmacia Letter 11/1997 Adobe Acrobat PDF Document hyperlink opens in a new browser window
131 kb
Letter from Pharmacia and Upjohn 10/1997 Adobe Acrobat PDF Document hyperlink opens in a new browser window
regarding private label packaging
131 kb
Annual Guidance 10/1997 Adobe Acrobat PDF Document hyperlink opens in a new browser window
178 kb
Dear Manufacturer Letter 10/1997 Adobe Acrobat PDF Document hyperlink opens in a new browser window
regarding record retention, 2-step computation, transferring covered drugs from one manufacturer to another, and custom or private label packaging
198 kb
Dear Manufacturer Letter 02/1997 Adobe Acrobat PDF Document hyperlink opens in a new browser window
regarding penny prices for single schedule companies
93 kb
Annual Guidance 10/1996 Adobe Acrobat PDF Document hyperlink opens in a new browser window
178 kb
Supplementary Guidance 10/1996 Adobe Acrobat PDF Document hyperlink opens in a new browser window
regarding nominal prices, drug samples and TRICARE
149 kb
Annual Guidance 09/1995 Adobe Acrobat PDF Document hyperlink opens in a new browser window
159 kb
Dear Manufacturer Letter 09/1995 Adobe Acrobat PDF Document hyperlink opens in a new browser window
conveying common errors observed by the Office of the Inspector General in the computation of the FCPs
169 kb
Annual Guidance 09/1994 Adobe Acrobat PDF Document hyperlink opens in a new browser window
192 kb
Dear I.V. Solutions Manufacturer Letter 10/1993 Adobe Acrobat PDF Document hyperlink opens in a new browser window
regarding covered drug status of certain I.V. Solutions
52 kb
Annual Guidance 10/1993 Adobe Acrobat PDF Document hyperlink opens in a new browser window
210 kb
Addition of New Covered Drugs 09/1993 Adobe Acrobat PDF Document hyperlink opens in a new browser window
139 kb
Office of General Counsel Letter 07/1993 Adobe Acrobat PDF Document hyperlink opens in a new browser window
regarding delegation of Hearing Responsibility, Title VI, P.L. 102-585, Drug Pricing Agreement
128 kb
Dear Manufacturer Letter 06/1993 Adobe Acrobat PDF Document hyperlink opens in a new browser window
regarding sales from "any State or Territory of the United States, the District of Columbia, and the Commonwealth of Puerto Rico"
57 kb
Office of General Counsel Letter 05/1993 Adobe Acrobat PDF Document hyperlink opens in a new browser window
Dear Manufacturer Letter 10/1997 Adobe Acrobat PDF Document hyperlink opens in a new browser window
regarding transfer of covered drugs
79 kb
Dear Manufacturer Letter 05/1993 Adobe Acrobat PDF Document hyperlink opens in a new browser window
regarding technical amendment to the P.L. (dual pricing)
234 kb
Dear Member of the I.V. Solutions Industry Letter 04/1993 Adobe Acrobat PDF Document hyperlink opens in a new browser window
regarding the covered status of I.V. Solutions
93 kb
Dear Radiopharmaceutical Industry Member Letter 04/1993 Adobe Acrobat PDF Document hyperlink opens in a new browser window
regarding agreement between the Department
and the manufacturer that Radiopharmacies will not be
considered wholesalers
80 kb
Assistant General Counsel Letter 03/1993 Adobe Acrobat PDF Document hyperlink opens in a new browser window
to the Deputy Assistant Secretary for Acquisition and Materiel Management regarding Impact of Public Law 102-585 on FSS Contract Pricing
200 kb
Dear Manufacturer Letter 02/1993 Adobe Acrobat PDF Document hyperlink opens in a new browser window
regarding request for increase to the FCP
137 kb
Dear Radiopharmacy Operator Letter 02/1993 Adobe Acrobat PDF Document hyperlink opens in a new browser window
regarding whether Radiopharmacies need to enter into Master Agreements
80 kb
Dear Manufacturer Letter 12/1992 Adobe Acrobat PDF Document hyperlink opens in a new browser window
regarding request for increase to the FCP
88 kb
Annual Guidance 11/1992 Adobe Acrobat PDF Document hyperlink opens in a new browser window
85 kb
Correspondence Archive Compressed File hyperlink opens in a new browser window
4866 kb

Back to topBack to top